Clinical TrialsCompass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Compass Pathways Reports 6-Month Phase 3 Data Showing Durable COMP360 Benef... Read Post »
Clinical TrialsTeva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Teva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Read Post »
Clinical TrialsHengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Hengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Read Post »
Clinical TrialsTvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Tvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Read Post »
Clinical TrialsItalfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Italfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Read Post »
Clinical TrialsTG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... Read Post »
Clinical TrialsOpus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Opus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Read Post »
Clinical TrialsFDA Accepts Pharvaris’ Deucrictibant NDA for HAE FDA Accepts Pharvaris’ Deucrictibant NDA for HAE Read Post »
Clinical TrialsIndian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Indian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Read Post »
Clinical TrialsWHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... WHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... Read Post »
Clinical TrialsBrii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Brii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Read Post »
Clinical TrialsCould a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Could a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Read Post »
Clinical TrialsNeurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Neurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Read Post »
Clinical TrialsAcoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Read Post »
Clinical TrialsRevolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Revolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Read Post »
Clinical TrialsRoche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Roche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Read Post »
Clinical TrialsGlenmark Advances Global Phase 3 Trial of Trastuzumab Rezetecan in Platinum... Glenmark Advances Global Phase 3 Trial of Trastuzumab Rezetecan in Platinum... Read Post »
Clinical TrialsVOYXACT Becomes First APRIL Inhibitor to Stabilize eGFR in Phase 3 VISIONAR... VOYXACT Becomes First APRIL Inhibitor to Stabilize eGFR in Phase 3 VISIONAR... Read Post »
Clinical TrialsCan-Fite Reports Durable Survival with Namodenoson in Heavily Pretreated Pa... Can-Fite Reports Durable Survival with Namodenoson in Heavily Pretreated Pa... Read Post »
Clinical TrialsNew ITC Analyses Support Overall Survival Benefit of Mogamulizumab in CTCL New ITC Analyses Support Overall Survival Benefit of Mogamulizumab in CTCL Read Post »
Clinical TrialsBeOne’s BRUKINSA Plus Rituximab Cuts Progression Risk by 43% in First-Lin... BeOne’s BRUKINSA Plus Rituximab Cuts Progression Risk by 43% in First-Lin... Read Post »
Clinical TrialsSkyhawk Reports Positive 12-Month Phase 1/2 SKY-0515 Data in HuntingtonR... Skyhawk Reports Positive 12-Month Phase 1/2 SKY-0515 Data in HuntingtonR... Read Post »
Clinical TrialsSanofi’s Nexviazyme Meets All Endpoints in Phase 3 Baby-COMET Study for I... Sanofi’s Nexviazyme Meets All Endpoints in Phase 3 Baby-COMET Study for I... Read Post »
Clinical TrialsAkebia Ends VOICE Trial Early as Vafseo Shows Superior Safety Over ESAs Akebia Ends VOICE Trial Early as Vafseo Shows Superior Safety Over ESAs Read Post »
Clinical TrialsVistagen Eyes New Registration Strategy After Fasedienol Phase 3 Miss Vistagen Eyes New Registration Strategy After Fasedienol Phase 3 Miss Read Post »
Clinical TrialsAscendis’s TransCon CNP Improved Leg Alignment Through Two Years in C... Ascendis’s TransCon CNP Improved Leg Alignment Through Two Years in C... Read Post »
Clinical TrialsAbivax Reports Positive Phase 3 Maintenance Data for Obefazimod in Refracto... Abivax Reports Positive Phase 3 Maintenance Data for Obefazimod in Refracto... Read Post »
Clinical TrialsEVO756 Fails Phase 2b CSU Trial, Evommune Shifts Focus to Atopic Dermatitis... EVO756 Fails Phase 2b CSU Trial, Evommune Shifts Focus to Atopic Dermatitis... Read Post »
Clinical TrialsAbbVie Phase 3 Trial Shows Epcoritamab Combination Significantly Extends Pr... AbbVie Phase 3 Trial Shows Epcoritamab Combination Significantly Extends Pr... Read Post »
Clinical TrialsViatris Reports Positive Phase 3 Results for VR-205 in Japanese IgA Nephrop... Viatris Reports Positive Phase 3 Results for VR-205 in Japanese IgA Nephrop... Read Post »
Clinical TrialsGrünenthal Moves NOP Agonist into Phase II After Positive Phase I Results Grünenthal Moves NOP Agonist into Phase II After Positive Phase I Results Read Post »
Clinical TrialsAvecho Advances Phase III CBD Insomnia Trial After Positive Interim Review ... Avecho Advances Phase III CBD Insomnia Trial After Positive Interim Review ... Read Post »
Clinical TrialsSamsung Bioepis Reports Positive Clinical Results for Pembrolizumab Biosimi... Samsung Bioepis Reports Positive Clinical Results for Pembrolizumab Biosimi... Read Post »
Clinical TrialsOral Infigratinib Phase 3 PROPEL 3 Results Published in NEJM, Adding New Ar... Oral Infigratinib Phase 3 PROPEL 3 Results Published in NEJM, Adding New Ar... Read Post »
Clinical TrialsAstra Zeneca’s Efzimfotase Alfa Improves Bone Health in Hypophosphata... Astra Zeneca’s Efzimfotase Alfa Improves Bone Health in Hypophosphata... Read Post »
Clinical TrialsEpicrispr’s EPI-321 Shows Early Muscle Gain and Favorable Safety in First... Epicrispr’s EPI-321 Shows Early Muscle Gain and Favorable Safety in First... Read Post »
Clinical TrialsHemab Reports Positive Early Data for HMB-002 in Von Willebrand Disease, Ad... Hemab Reports Positive Early Data for HMB-002 in Von Willebrand Disease, Ad... Read Post »
Clinical TrialsCumberland Reports New Biomarker Data Supporting Ifetroban’s Heart-Pr... Cumberland Reports New Biomarker Data Supporting Ifetroban’s Heart-Pr... Read Post »
Clinical TrialsJohnson & Johnson Reports New IMAAVY Data Supporting Early Disease Cont... Johnson & Johnson Reports New IMAAVY Data Supporting Early Disease Cont... Read Post »
Clinical TrialsCAR T-Cell Therapy Delivers 10-Year Remissions in B-Cell Lymphoma, Strength... CAR T-Cell Therapy Delivers 10-Year Remissions in B-Cell Lymphoma, Strength... Read Post »
Clinical TrialsCapricor Reports Five-Year Deramiocel Data Showing Sustained Muscle and Car... Capricor Reports Five-Year Deramiocel Data Showing Sustained Muscle and Car... Read Post »
Clinical TrialsServier to Present Three-Year OJEMDA Data and Caregiver Survey at ISPNO 202... Servier to Present Three-Year OJEMDA Data and Caregiver Survey at ISPNO 202... Read Post »
Clinical TrialsTegoprubart Shows Superior Kidney Function to Tacrolimus in Phase 2 BESTOW ... Tegoprubart Shows Superior Kidney Function to Tacrolimus in Phase 2 BESTOW ... Read Post »
Clinical TrialsAxsome Doses First Patient in Phase 3 FOCUS-3 Trial of Solriamfetol for Ado... Axsome Doses First Patient in Phase 3 FOCUS-3 Trial of Solriamfetol for Ado... Read Post »
Clinical TrialsGENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... GENFIT Reports Positive Results for GNS561 Combination in KRAS-Mutated Chol... Read Post »
Clinical TrialsCentanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Centanafadine Improves ADHD and Anxiety Symptoms in Phase 3b Trial Ahead of... Read Post »
Clinical TrialsCeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results CeleCor Submits NDA for Zalunfiban After Positive CeleBrate Trial Results Read Post »
Clinical TrialsHUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... HUTCHMED Reports Positive Results for Fanregratinib in FGFR2-Altered Intrah... Read Post »
Clinical TrialsAvacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Avacta Reports Positive Data for Faridoxorubicin in Salivary Gland Cancer Read Post »
Clinical TrialsCognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Cognition Aligns with FDA on Phase 3 Pathway for Zervimesine in Dementia wi... Read Post »
